Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients

Clinical Transplantation

Volumn 19, Issue 4, 2005, Pages 527-531

  Walczak, Debra A ^a   Calvert, Denise ^a   Jarzembowski, Tomasz M ^a   Testa, Giuliano ^a   Sankary, Howard N ^a   Thielke, James ^a   Oberholzer, José ^a   Benedetti, Enrico ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Post transplant diabetes; Steroid discontinuation

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; CREATININE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; BODY WEIGHT DISORDER; CAUCASIAN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GRAFT SURVIVAL; HISPANIC; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RACE DIFFERENCE; RECIPIENT; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; TREATMENT WITHDRAWAL;

ADULT; DIABETES MELLITUS; FEMALE; GRAFT SURVIVAL; HISPANIC AMERICANS; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STEROIDS; TACROLIMUS;

EID: 22244452014     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00383.x     Document Type: Review

References (21)

1. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to post-receptor defect of insulin action. J Clin Endocrinol Metab 1982: 54: 131.
2. van Duijnhoven EM, Boots JM, Christiaans MH, van Hoof JP. Metabolic aspects of tacrolimus in renal transplantation. Consequences for the choice of an immunosuppressive regimen and for management of post-transplant diabetes mellitus. Minerva Urol Nefrol 2003: 55: 33.
3. Cosio FG, Pesavento TE, Osei K, Henry M, Ferguson RM. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001: 59: 732.
4. Jindal RM, Hjelmesaeth J. Impact and management of post-transplant diabetes mellitus. Transplantation 2000: 70 (Suppl.): SS58.
5. Neylan JF. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. Transplantation 1998: 65: 515.
6. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003: 3: 178.
7. Miles AM, Surami N, Horowitz R et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation 1998: 65: 380.
8. Woodward R, Schnitzler MA, Baty J, Lowell JA, Lopez L. Incidence and cost of new onset diabetes mellitus among US wait-listed and transplanted renal allograft recipients. Am J Transplant 2003: 3: 589.
9. Matas AJ. Prednisone withdrawal in kidney transplant recipients on cyclosporine and MMF: A prospective randomized study. Transplantation 1999: 68: 1865.
10. Woodle ES, Buell J, Siegel C, Kulkarni S, Kopelan A, Grewas HP. Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience. Transplant Proc 1999: 31: 84S.
11. Buell JF, Kulkarni S, Grewal HP et al. Early corticosteroid cessation at one week following kidney transplant under tacrolimus and mycophenolate mofetil immunosuppression, three year follow-up [abstract]. Transplantation 2000: 69: S134.
12. Hirano Y, Hisatomi A, Ohara K, Noguchi H. The effects of FK506 and cyclosporine on the exocrine function of the rat pancreas. Transplantation 1992: 54: 883.
13. Hariharan S, Johnson CP, Breshnahan BA et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000: 342: 605.
14. Ojo AO, Hanson JA, Wolfe RA et al. Long-term survival in renal transplantation recipients with graft function. Kidney Int 2000: 57: 307.
15. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998: 21: 296.
16. Pirsch JD, Miller J, Deierhoi MH et al. A comparison of tacrolimus and cyclosporine for immunosupression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997: 63: 977.
17. Friedman EA, Shyh TP, Beyer MM, Manis T, Butt KMH. Post-transplant diabetes in kidney transplant recipients. Am J Nephrol 1985: 5: 196.
18. Davis R, Daskalakis P, Friedman EA et al. Posttransplant diabetes mellitus in cyclosporine treated renal transplant recipients. Transplant Proc 1991: 23: 1249.
19. Weir M, Fink J. Risk for post-transplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999: 34: 1.
20. Ritz E, Rychlik I, Locatelli F et al. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 1999: 34: 795.
21. Osei K, Gaillard T, Schuster DP. Pathogenic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness. Diabetes Care 1997: 20: 396.